|
US6214331B1
(en)
*
|
1995-06-06 |
2001-04-10 |
C. R. Bard, Inc. |
Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained
|
|
AR018321A1
(es)
*
|
1998-03-26 |
2001-11-14 |
Alza Corp |
Una forma de dosificacion de liberacion prolongada que comprende oxibutinina y los usos de la oxibutinina y de la forma de dosificacion de liberacionprolongada.
|
|
US6623751B2
(en)
*
|
1998-07-30 |
2003-09-23 |
L'oreal S.A. |
Cosmetic, pharmaceutical, or dermatological patch
|
|
US6293923B1
(en)
|
1999-03-15 |
2001-09-25 |
Innoventions, Inc. |
Intravesicular balloon
|
|
US6383471B1
(en)
*
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
|
PL351948A1
(en)
*
|
1999-06-04 |
2003-07-14 |
Alza Corp |
Implantable gel compositions and method of making thereof
|
|
EP1949890A3
(en)
*
|
1999-06-04 |
2011-05-18 |
ALZA Corporation |
Implantable gel compositions and method of manufacture
|
|
US6527718B1
(en)
|
1999-08-20 |
2003-03-04 |
Brian G Connor |
Ultrasound system for continuous imaging and delivery of an encapsulated agent
|
|
US6740039B1
(en)
|
1999-08-20 |
2004-05-25 |
Koninklijke Philips Electronics N.V. |
Methods and apparatus for displaying information relating to delivery and activation of a therapeutic agent using ultrasound energy
|
|
JP2003531157A
(ja)
*
|
2000-04-26 |
2003-10-21 |
ワトソン ファーマシューティカルズ， インコーポレイテッド |
オキシブチニン治療に関連した有害な経験の最小化
|
|
US7179483B2
(en)
*
|
2000-04-26 |
2007-02-20 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
|
US7029694B2
(en)
*
|
2000-04-26 |
2006-04-18 |
Watson Laboratories, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
|
US20030124177A1
(en)
*
|
2000-04-26 |
2003-07-03 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
|
US6398718B1
(en)
|
2000-06-15 |
2002-06-04 |
Innoventions, Inc. |
Intravesicular device
|
|
US6545046B2
(en)
|
2000-08-30 |
2003-04-08 |
Theramax Inc. |
Method for enhanced delivery of oxybutynin and compositions thereof
|
|
US6699665B1
(en)
*
|
2000-11-08 |
2004-03-02 |
Surface Logix, Inc. |
Multiple array system for integrating bioarrays
|
|
US6899703B2
(en)
*
|
2001-03-13 |
2005-05-31 |
Clemson University |
Intraurethral device for treating or detecting various diseases or infections of the urinary system
|
|
US6558312B2
(en)
|
2001-03-13 |
2003-05-06 |
Clemson University |
Intraurethral device for incontinence
|
|
KR100426636B1
(ko)
*
|
2001-05-18 |
2004-04-08 |
한국과학기술연구원 |
주사 가능한 젤 상의 조성물 및 그의 제조방법
|
|
US6702744B2
(en)
*
|
2001-06-20 |
2004-03-09 |
Advanced Cardiovascular Systems, Inc. |
Agents that stimulate therapeutic angiogenesis and techniques and devices that enable their delivery
|
|
US8110217B2
(en)
*
|
2001-08-13 |
2012-02-07 |
University Of Pittsburgh |
Sphingomyelin liposomes for the treatment of hyperactive bladder disorders
|
|
US7063860B2
(en)
*
|
2001-08-13 |
2006-06-20 |
University Of Pittsburgh |
Application of lipid vehicles and use for drug delivery
|
|
US20050227911A1
(en)
*
|
2001-09-28 |
2005-10-13 |
Solubest Ltd. |
Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules
|
|
US6878693B2
(en)
|
2001-09-28 |
2005-04-12 |
Solubest Ltd. |
Hydrophilic complexes of lipophilic materials and an apparatus and method for their production
|
|
US20050233003A1
(en)
*
|
2001-09-28 |
2005-10-20 |
Solubest Ltd. |
Hydrophilic dispersions of nanoparticles of inclusion complexes of salicylic acid
|
|
US6893431B2
(en)
|
2001-10-15 |
2005-05-17 |
Scimed Life Systems, Inc. |
Medical device for delivering patches
|
|
ATE493126T1
(de)
*
|
2001-11-01 |
2011-01-15 |
Spectrum Pharmaceuticals Inc |
Medizinische zusammensetzungen zur intravesikalen behandlung von blasenkrebs
|
|
US8563592B2
(en)
|
2001-11-01 |
2013-10-22 |
Spectrum Pharmaceuticals, Inc. |
Bladder cancer treatment and methods
|
|
US7700851B2
(en)
*
|
2001-11-13 |
2010-04-20 |
U.S. Smokeless Tobacco Company |
Tobacco nicotine demethylase genomic clone and uses thereof
|
|
US8608661B1
(en)
|
2001-11-30 |
2013-12-17 |
Advanced Cardiovascular Systems, Inc. |
Method for intravascular delivery of a treatment agent beyond a blood vessel wall
|
|
US8685427B2
(en)
|
2002-07-31 |
2014-04-01 |
Boston Scientific Scimed, Inc. |
Controlled drug delivery
|
|
US8133501B2
(en)
|
2002-02-08 |
2012-03-13 |
Boston Scientific Scimed, Inc. |
Implantable or insertable medical devices for controlled drug delivery
|
|
US7361368B2
(en)
|
2002-06-28 |
2008-04-22 |
Advanced Cardiovascular Systems, Inc. |
Device and method for combining a treatment agent and a gel
|
|
US8920826B2
(en)
*
|
2002-07-31 |
2014-12-30 |
Boston Scientific Scimed, Inc. |
Medical imaging reference devices
|
|
US7149874B2
(en)
*
|
2002-08-16 |
2006-12-12 |
Micron Technology, Inc. |
Memory hub bypass circuit and method
|
|
CA2503193A1
(en)
*
|
2002-10-22 |
2004-05-06 |
The Biomerix Corporation |
Method and system for intravesicular delivery of therapeutic agents
|
|
US7597903B2
(en)
*
|
2002-12-02 |
2009-10-06 |
Shenkar College Of Engineering And Design |
Method and composition for producing catheters with antibacterial property
|
|
US20060058777A1
(en)
*
|
2002-12-11 |
2006-03-16 |
Pia Norup Nielsen |
Urinary catheter device with a pharmaceutically active composition
|
|
JP2004246317A
(ja)
*
|
2002-12-20 |
2004-09-02 |
Hitachi Ltd |
冷陰極型フラットパネルディスプレイ
|
|
JP2006520786A
(ja)
|
2003-03-14 |
2006-09-14 |
シネクサス， インコーポレイテッド |
徐放性治療剤の洞送達
|
|
US8383158B2
(en)
*
|
2003-04-15 |
2013-02-26 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions to treat myocardial conditions
|
|
US8038991B1
(en)
|
2003-04-15 |
2011-10-18 |
Abbott Cardiovascular Systems Inc. |
High-viscosity hyaluronic acid compositions to treat myocardial conditions
|
|
US8821473B2
(en)
|
2003-04-15 |
2014-09-02 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions to treat myocardial conditions
|
|
JP2007521843A
(ja)
|
2003-05-15 |
2007-08-09 |
バイオメリクス コーポレーション |
網状化エラストマー系マトリックス、その製造、及び移植可能な装置における使用
|
|
US20040249364A1
(en)
*
|
2003-06-03 |
2004-12-09 |
Ilya Kaploun |
Device and method for dispensing medication to tissue lining a body cavity
|
|
WO2005007074A2
(en)
*
|
2003-07-21 |
2005-01-27 |
Bio-Dar Ltd. |
Gellan gum based oral controlled release dosage forms- a novel platform technology for gastric retention
|
|
NZ528648A
(en)
|
2003-10-02 |
2005-08-26 |
Agres Ltd |
Altering animal waste composition
|
|
US20050175709A1
(en)
*
|
2003-12-11 |
2005-08-11 |
Baty Ace M.Iii |
Therapeutic microparticles
|
|
US7763077B2
(en)
|
2003-12-24 |
2010-07-27 |
Biomerix Corporation |
Repair of spinal annular defects and annulo-nucleoplasty regeneration
|
|
WO2006013851A1
(ja)
*
|
2004-08-03 |
2006-02-09 |
Nippon Shinyaku Co., Ltd. |
体孔内用デバイス及び持続性製剤
|
|
US8361490B2
(en)
|
2004-09-16 |
2013-01-29 |
Theracoat Ltd. |
Biocompatible drug delivery apparatus and methods
|
|
US7854944B2
(en)
|
2004-12-17 |
2010-12-21 |
Advanced Cardiovascular Systems, Inc. |
Tissue regeneration
|
|
CA2603081C
(en)
|
2005-04-04 |
2013-09-03 |
Sinexus, Inc. |
Device and methods for treating paranasal sinus conditions
|
|
US8187621B2
(en)
*
|
2005-04-19 |
2012-05-29 |
Advanced Cardiovascular Systems, Inc. |
Methods and compositions for treating post-myocardial infarction damage
|
|
US9539410B2
(en)
|
2005-04-19 |
2017-01-10 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions for treating post-cardial infarction damage
|
|
US20080125745A1
(en)
|
2005-04-19 |
2008-05-29 |
Shubhayu Basu |
Methods and compositions for treating post-cardial infarction damage
|
|
US8303972B2
(en)
*
|
2005-04-19 |
2012-11-06 |
Advanced Cardiovascular Systems, Inc. |
Hydrogel bioscaffoldings and biomedical device coatings
|
|
US8828433B2
(en)
|
2005-04-19 |
2014-09-09 |
Advanced Cardiovascular Systems, Inc. |
Hydrogel bioscaffoldings and biomedical device coatings
|
|
CA2653541C
(en)
|
2005-06-06 |
2014-12-23 |
The University Of British Columbia |
Polymer-based serum albumin substitute
|
|
DK1933810T3
(da)
*
|
2005-08-11 |
2013-01-28 |
Childrens Medical Center |
Intravesikal lægemiddelafgivelsesindretning og fremgangsmåde
|
|
US7732190B2
(en)
*
|
2006-07-31 |
2010-06-08 |
Advanced Cardiovascular Systems, Inc. |
Modified two-component gelation systems, methods of use and methods of manufacture
|
|
US9242005B1
(en)
|
2006-08-21 |
2016-01-26 |
Abbott Cardiovascular Systems Inc. |
Pro-healing agent formulation compositions, methods and treatments
|
|
WO2008035172A2
(en)
*
|
2006-09-18 |
2008-03-27 |
Glenmark Pharmaceuticals Limited |
Pharmaceutical compositions containing desmopressin
|
|
US8741326B2
(en)
*
|
2006-11-17 |
2014-06-03 |
Abbott Cardiovascular Systems Inc. |
Modified two-component gelation systems, methods of use and methods of manufacture
|
|
US9005672B2
(en)
|
2006-11-17 |
2015-04-14 |
Abbott Cardiovascular Systems Inc. |
Methods of modifying myocardial infarction expansion
|
|
US8192760B2
(en)
|
2006-12-04 |
2012-06-05 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions for treating tissue using silk proteins
|
|
US20080161639A1
(en)
*
|
2006-12-28 |
2008-07-03 |
Olympus Medical Systems Corporation |
Capsule medical apparatus and body-cavity observation method
|
|
US8702591B2
(en)
*
|
2007-01-12 |
2014-04-22 |
Olympus Medical Systems Corp. |
Capsule medical apparatus
|
|
DE102007003765A1
(de)
*
|
2007-01-19 |
2008-07-24 |
Farco-Pharma Gmbh |
Pharmazeutische Zusammensetzung zur Behandlung von Inkontinenz
|
|
KR101538748B1
(ko)
*
|
2007-12-11 |
2015-07-22 |
메사추세츠 인스티튜트 오브 테크놀로지 |
이식형 의약 투여 장치와 방광과 기타 신체 낭 또는 내강의 치료 방법
|
|
PT2231065T
(pt)
|
2007-12-18 |
2020-12-07 |
Intersect Ent Inc |
Dispositivos autoexpansíveis
|
|
AU2009276505B2
(en)
|
2008-08-01 |
2015-04-23 |
Intersect Ent, Inc. |
Methods and devices for crimping self-expanding devices
|
|
EA201170297A1
(ru)
*
|
2008-08-09 |
2011-08-30 |
Массачусетс Инститьют Оф Текнолоджи |
Имплантируемое устройство для доставки лекарственных средств и способ лечения мужской мочеполовой системы и окружающих тканей
|
|
US20100291182A1
(en)
*
|
2009-01-21 |
2010-11-18 |
Arsenal Medical, Inc. |
Drug-Loaded Fibers
|
|
US8974368B2
(en)
|
2009-04-28 |
2015-03-10 |
Ams Research Corporation |
Pelvic tissue support devices
|
|
EP2427243A4
(en)
|
2009-05-05 |
2012-11-21 |
Vapogenix Inc |
NEW FORMULATIONS OF VOLATILE ANESTHETICS AND METHOD OF ADMINISTRATION
|
|
AU2010248992B2
(en)
|
2009-05-15 |
2014-11-27 |
Intersect Ent, Inc. |
Expandable devices and methods therefor
|
|
CN101724163B
(zh)
*
|
2009-06-23 |
2011-09-07 |
河南科技大学 |
一种壳聚糖衍生物复合微球及其制备方法和应用
|
|
DK2445570T3
(da)
|
2009-06-26 |
2013-02-25 |
Taris Biomedical Inc |
Implanterbare lægemiddelafgivelsesindretninger samt fremgangsmåder til deres fremstilling
|
|
DE102009035586A1
(de)
|
2009-07-31 |
2011-02-03 |
Fresenius Kabi Deutschland Gmbh |
Intravesikale Instillationslösungen zur Behandlung von Blasenkrebs
|
|
US20110202016A1
(en)
*
|
2009-08-24 |
2011-08-18 |
Arsenal Medical, Inc. |
Systems and methods relating to polymer foams
|
|
US9044580B2
(en)
|
2009-08-24 |
2015-06-02 |
Arsenal Medical, Inc. |
In-situ forming foams with outer layer
|
|
US10420862B2
(en)
|
2009-08-24 |
2019-09-24 |
Aresenal AAA, LLC. |
In-situ forming foams for treatment of aneurysms
|
|
US9173817B2
(en)
|
2009-08-24 |
2015-11-03 |
Arsenal Medical, Inc. |
In situ forming hemostatic foam implants
|
|
US12544491B2
(en)
|
2009-08-24 |
2026-02-10 |
Arsenal Medical, Inc. |
In situ forming hemostatic foam implants
|
|
US9017312B2
(en)
|
2009-09-10 |
2015-04-28 |
Taris Biomedical Llc |
Implantable device for controlled drug delivery
|
|
PL3884988T3
(pl)
|
2009-12-17 |
2025-09-08 |
Taris Biomedical Llc |
Urządzenie implantowalne z tolerancją wewnątrzpęcherzową
|
|
AU2015201123B2
(en)
*
|
2009-12-17 |
2016-04-21 |
Taris Biomedical Llc |
Implantable device with intravesical tolerability and methods of treatment
|
|
ES2732150T3
(es)
|
2010-01-20 |
2019-11-20 |
Urogen Pharma Ltd |
Material y método para tratar cavidades internas
|
|
CN102906157B
(zh)
|
2010-03-01 |
2016-08-24 |
不列颠哥伦比亚大学 |
衍生的超支化聚丙三醇
|
|
EP3711750B1
(en)
|
2010-08-05 |
2023-09-06 |
TARIS Biomedical LLC |
Implantable drug delivery devices for genitourinary sites
|
|
WO2012048114A1
(en)
*
|
2010-10-06 |
2012-04-12 |
Taris Biomedical, Inc. |
Time-selective bioresorbable or collapsible drug delivery systems and methods
|
|
JP2014503554A
(ja)
|
2011-01-10 |
2014-02-13 |
タリス バイオメディカル，インコーポレイテッド |
膀胱痛及び刺激性排尿の持続的治療の使用のためのリドカインレジメン
|
|
US8968626B2
(en)
|
2011-01-31 |
2015-03-03 |
Arsenal Medical, Inc. |
Electrospinning process for manufacture of multi-layered structures
|
|
US9194058B2
(en)
|
2011-01-31 |
2015-11-24 |
Arsenal Medical, Inc. |
Electrospinning process for manufacture of multi-layered structures
|
|
US9034240B2
(en)
|
2011-01-31 |
2015-05-19 |
Arsenal Medical, Inc. |
Electrospinning process for fiber manufacture
|
|
EP2670398B1
(en)
|
2011-02-04 |
2017-06-07 |
TARIS Biomedical LLC |
Implantable device for controlled release of low solubility drug
|
|
US8476221B2
(en)
|
2011-03-18 |
2013-07-02 |
Halimed Pharmaceuticals, Inc. |
Methods and compositions for the treatment of metabolic disorders
|
|
EP2734187B1
(en)
|
2011-07-20 |
2018-09-05 |
UroGen Pharma Ltd. |
Materials and method for treating internal body cavities
|
|
HUE032240T2
(en)
|
2011-10-24 |
2017-09-28 |
Asana Biosciences Llc |
cyclohexylamines
|
|
US8993831B2
(en)
|
2011-11-01 |
2015-03-31 |
Arsenal Medical, Inc. |
Foam and delivery system for treatment of postpartum hemorrhage
|
|
EP2849725B1
(en)
|
2012-05-19 |
2020-11-25 |
TARIS Biomedical LLC |
Implantable urological device with improved retrieval feature
|
|
EP2968877B1
(en)
|
2013-03-14 |
2020-01-01 |
Intersect ENT, Inc. |
Systems and devices for treating a sinus condition
|
|
KR102557326B1
(ko)
|
2013-03-15 |
2023-07-19 |
타리스 바이오메디컬 엘엘씨 |
약물-투과성 구성요소를 가지는 약물 전달 장치
|
|
KR102385603B1
(ko)
|
2013-08-19 |
2022-04-11 |
타리스 바이오메디컬 엘엘씨 |
다중 유닛 약물 전달 장치 및 방법
|
|
JP6616772B2
(ja)
|
2013-12-16 |
2019-12-04 |
アサナ・バイオサイエンシズ，リミテッド・ライアビリティ・カンパニー |
Ｐ２ｘ３および／またはｐ２ｘ２／３化合物ならびに方法
|
|
CN103861091B
(zh)
*
|
2014-03-20 |
2016-04-27 |
辽宁亿灵科创生物医药科技有限公司 |
治疗膀胱炎的药物组合物
|
|
KR20220061253A
(ko)
|
2014-06-26 |
2022-05-12 |
타리스 바이오메디컬 엘엘씨 |
탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법
|
|
CZ308594B6
(cs)
*
|
2014-09-29 |
2020-12-23 |
VÝZKUMNÝ ÚSTAV VETERINÁRNÍHO LÉKAŘSTVÍ, v.v.i. |
Mukoadhezivní nosiče částic, způsob přípravy a použití
|
|
CN107427668B
(zh)
|
2015-01-22 |
2021-09-03 |
因特尔赛克特耳鼻喉公司 |
药物涂覆的气囊
|
|
WO2016172704A1
(en)
|
2015-04-23 |
2016-10-27 |
Taris Biomedical Llc |
Drug delivery devices with drug-permeable component and methods
|
|
CN109996546B
(zh)
|
2016-09-30 |
2023-06-27 |
阿沙纳生物科学公司 |
P2x3和/或p2x2/3化合物及方法
|
|
US20180256867A1
(en)
*
|
2017-03-07 |
2018-09-13 |
Bruce H. Levin |
Nasal Delivery Device and Methods of Use
|
|
IT201700104446A1
(it)
|
2017-09-19 |
2019-03-19 |
Lo Li Pharma Srl |
Compositions, uses and methods for treatment of infertility and subfertility
|
|
WO2019122119A1
(en)
|
2017-12-22 |
2019-06-27 |
Lo.Li. Pharma International S.R.L. |
Treatment of fibrosis with inositol
|
|
EP3856143A4
(en)
*
|
2018-09-27 |
2022-07-06 |
Watershed Medical, Inc. |
DEVICE AND METHOD FOR TREATING INFECTIONS
|
|
WO2020168244A1
(en)
|
2019-02-15 |
2020-08-20 |
Incelldx, Inc. |
Assaying bladder-associated samples, identifying and treating bladder-associated neoplasia, and kits for use therein
|
|
IT201900003843A1
(it)
|
2019-03-15 |
2020-09-15 |
Lo Li Pharma Srl |
Trattamento di fibromi con vitamina D e un agente come l'epigallocatechina gallato (EGCG)
|
|
AU2020265812B2
(en)
*
|
2019-04-30 |
2025-08-28 |
Trigone Pharma Ltd. |
Formulations and methods for drug instillation into the bladder and treatment of bladder ailments
|
|
ES2947713T3
(es)
|
2019-06-13 |
2023-08-17 |
Hollister Inc |
Productos de catéter urinario reutilizables
|
|
WO2020263859A1
(en)
|
2019-06-25 |
2020-12-30 |
Hollister Incorporated |
Reusable urinary catheter products
|
|
US12403291B2
(en)
|
2019-08-30 |
2025-09-02 |
Intersect Ent, Inc. |
Submucosal bioresorbable drug eluting platform
|
|
US20210100950A1
(en)
|
2019-10-02 |
2021-04-08 |
Watershed Medical, Inc. |
Device and method for improving retention of a therapy in the bladder
|
|
CA3249723A1
(en)
*
|
2022-04-19 |
2023-10-26 |
Watershed Medical, Inc. |
Formulation for treating urinary system disorders
|
|
IT202200013867A1
(it)
|
2022-06-30 |
2023-12-30 |
Lo Li Pharma Srl |
Composizione per il trattamento dell’ infezione da papilloma virus (hpv)
|